The global pharmaceutical market is likely to witness significant growth due to continuous R&D activities. Growth of geriatric population, rising government expenditure for healthcare, and improving economic conditions, especially in developing countries can propel market growth. High prevalence of lifestyle and chronic diseases is expected to boost market growth in the coming years. In addition, changing lifestyle and rapid socio-demographic shift due to urbanization in developed and emerging countries are likely to fuel the demand. Advancements in technology and introduction of novel drugs are key driving factors in the market.
The global protein therapeutics market is expected to exhibit notable growth in the coming years owing to high prevalence of chronic diseases and increasing awareness among individuals regarding effectiveness of protein therapies. Rising incidence of diabetes, cancer, and cardiovascular diseases has resulted in increased demand for these therapeutics owing to their minimal side effects. Proteins play an important role in maintaining healthy lifestyle.
The global breast cancer market is anticipated to witness a significant growth over the forecast period on account of growing target population base across the globe, rising prevalence of the disease, unhealthy lifestyle, exposure to radiations, and lack of physical exercises. Moreover, increasing efforts taken by major organizations across various regions to increase awareness levels is estimated to drive the market. Rising investments in R&D by various government and private organizations for development of effective drugs and treatments is also projected to play a key role in the market growth.
The global animal health market is poised to witness steady expansion in terms of revenue over the forecast period of 2017 to 2025. Advancing veterinary care technologies coupled with high prevalence of zoonotic diseases is expected to drive market growth. Rise in animal food-borne diseases globally is projected to promote adoption of pharmaceuticals and animal vaccines. This factor is expected to give a fillip to market expansion. Growing demand for protein rich food has given rise to commercial animal farming to increase production of meat cattle, milch, and other livestock.
The global human and animal vaccine adjuvants market size was valued at USD 517.7 million in 2017. The market is majorly driven by the growing prevalence of various chronic illnesses including cancer. Vaccine adjuvants are vital ingredients of many clinically approved vaccines. Federal agencies across the globe are striving to ensure immunization for every individual irrespective of their social and economic status.
The global somatostatin analogs market size was valued at USD 2,166 million in 2014 and is expected to witness a significant growth, pertaining to the rise in the prevalence of acromegaly and neuroendocrine tumors coupled with the rising investments in R&D activities.Somatostatin analogs are used as first line of treatment in conditions such as acromegaly, carcinoid syndrome, neuroendocrine tumor, Cushing syndrome and other related diseases. Somatostatin analogues work by inhibiting production of growth hormones and serotonin.
The global oligonucleotide testing market size was valued at USD 663.98 million in 2014 and is expected to witness a significant growth, pertaining to the rise in the technological advancements in synthesis of oligonucleotide products, introduction of strong pipeline programs, and increasing research activities in the segment over the forecast period. Oligonucleotide testing is majorly dependent on three factors namely modifications, application, and oligonucleotide length.
Doxorubicin is an anti-cancer chemotherapy drug. It is an intravenous injection through a central or peripheral venous line. No pill form of this drug is available in the market.
Globally, emerging technologies in the insulin drug and delivery field have shown potential in the diabetes market, with enhanced glucose control, along with well-accepted newer delivery methods.
The global antidiabetic drug market is expected to witness substantial growth over the forecast period on account of increasing occurrence of diabetes; both type I and type II and increasing obesity among people across the globe.
Dyslipidemia is an interminable metabolic disorder, described by improper level of low thickness lipoprotein, high thickness lipoprotein, and triglycerides.
The global type 1 diabetes market size was valued at USD 25.52 billion in 2016 and is expected to exhibit rewarding growth over the forecast period. This is majorly due to the significant increase in type 1 diabetes (T1D) prevalence followed by rising uptake of novel formulations of insulin analogs and auxiliary therapies.
The global herbal medicine market size was valued at USD 71.19 billion in 2016 and is expected to exhibit profitable growth over the forecast period. The increase is attributed to the increasing preference of consumers towards traditional medicines (Ayurveda, Unani and Traditional Chinese Medicine) which do not cause overdose toxicity and have fewer side effects. In addition, increasing substantial research investments and funding will support the market growth in near future.
The global medical morphine market size was valued at USD 10.75 billion in 2016. Increasing use of the drug to relieve pain in cancer, arthritis and postoperative surgeries is expected to drive market growth over the forecast period.
The global pharmerging market is anticipated to witness steady CAGR over the forecast period. Factors such as rising population due to low infant mortality rates and high focus on developing innovative drugs are expected to boost the growth. Among 17 emerging countries; China, India, and Russia are projected to hold a major market share in near future.
The China bioprocess instruments market size was estimated at USD 1.18 billion in 2016 and is expected to grow on account of the evolution of new technologies.
Medicine cabinet is made for medicine storing to be clear and safe. Medicines should be stored in ordered cabinets so that regularly there are different places for antibiotics, narcotics, oral suspensions and medicines that require a cool storing. Medicines that need to be protected from light can usually be placed in a normal medicine cabinet. Medicine cabinets should also be protected from moist.
MMR vaccine is also known as MPR vaccine. It is an immunization vaccine against measles, mumps and rubella. It is a mixture of live attenuated viruses of the three diseases, administered via injection. The measles, mumps and rubella (MMR) vaccine is recommended for all children. It protects against three potentially serious illnesses. It is a two-part vaccination, and in most states, you must prove your children have gotten it before they can enter school.
Polio vaccines are the vaccines that are employed to avert the rates of poliomyelitis. Two kinds of polio vaccines are available. The first one deploys inactivated poliovirus and is offered via injection and the other one utilizes weakened poliovirus which is offered through mouth. It has been found that it is quite secure to use the inactivated polio vaccines. At times what happens, at the site of injection, mild redness or pain occurs.
An attenuated vaccine is a type of vaccine produced by lessening the virulence of a pathogen, but still maintaining the state of viability. This process of attenuation initially gets an infectious agent and modifies it in order to make it harmless or less virulent. These vaccines are formed by raising the virus in tissue cultures that will go for less virulent strains.
A vaccine used to prevent genital warts, anal cancer, cervical cancer, vulvar cancer, and vaginal cancer caused by certain types of human papillomavirus (HPV). It is also used to prevent lesions that are caused by those viruses and that can lead to anal, cervical, vulvar, or vaginal cancer. Also called human papillomavirus vaccine.
Contraceptives serve the dual purpose of protecting people from pregnancy & sexually transmitted diseases. According to Hexa Research, the global contraceptives market is predicted over USD 31 million by 2024.
The sevoflurane, isoflurane and desflurane market is expected to reach USD 1.5 billion by 2022 in comparison to USD 1.2 billion in 2014.
Market research report on Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market by Hexa Research provides a clear picture about the worldwide development of the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics industry and recent key trends based on detailed statistical analysis. This new report provides latest market data, including market estimate and forecast by application and product on a regional basis for historic years of 2012 and 2013 with forecast up to 2020. This report is an invaluable resource for industry executives looking for key market data in readily available and clearly presented graphs and tables. Major regional markets covered in this report include North America, Europe, Asia Pacific and Rest of the world.
Catheters market is expected to grow over the forecast period owing to the increasing prevalence of cardiovascular diseases and growing demand for minimally invasive medical procedures. The other growth drivers of this market are growing incidences of lifestyle induced diseases such as obesity & diabetes, sophisticated healthcare infrastructure, increasing population and awareness.
Increasing prevalence of type I and type II diabetes is expected to drive the entire insulin market over the forecast period. Basically, insulin is a peptide hormone secreted with the help of beta cells by pancreas. The main function of insulin is to enable the absorption of glucose from the blood in the body which provides energy to the body and stabilize the level of blood glucose.
Increasing pharmaceutical products demand and growing global geriatric population is expected to boost the global excipient market growth over the next five years. Excipients are inert or inactive substances, used to serve as medium or vehicle for active pharmaceutical ingredients (API). Excipients are generally used as integrants, flavoring agents, binders and coating agents in pharmaceutical industry to manufacture capsules and tablets.
Contraceptive drugs and devices market is expected to grow over the forecast period owing to the increasing prevalence of sexually transmitted diseases such as HIV & HPV and growing population. The other drivers of this market are increasing government & NGO’s programs against the abortion, social & political consideration, and changing lifestyle.